Nanoparticles for Immune Cell Reprogramming and Reengineering of Tumor Microenvironment
Nanoparticles in cancer therapy have garnered significant attention in the past few decades. Cancer immunotherapy, which is aptly called “the new-generation cancer therapy,” is slowly making remarkable strides in the improvement of patient outcome and longevity. Taken together, nanoparticles in immune therapy have the potential to offer advantages of both nanoparticles and immune therapy on a single platform.
KeywordsCancer Macrophage polarization Immune therapy Immune cell reprogramming Nanoparticles
The authors acknowledge partial support for this work by Wayne State University startup funding. A.K.I. acknowledges a grant from the Department of Defense (DoD) CDMRP KCRP Idea Development Award (#W81XWH-18-1-0471) as an Early Career Investigator. S.S. and A.K.I. acknowledge a grant support from the Burroughs Wellcome Trust. K.B. acknowledges Thomas C. Rumble University Graduate Fellowship and Graduate Research Fellowship from the Wayne State University. R.A. acknowledges the scholarship support from College of Pharmacy at Taif University and Saudi Arabian Cultural Mission (SACM).
- 3.Xie Z et al (2017) Immune cell-mediated biodegradable theranostic nanoparticles for melanoma targeting and drug delivery. Small 13:1–10Google Scholar
- 9.Sau S et al (2018) Abstract 4660: tumor multicomponent targeting nanoparticle library for personalized cancer therapy and imaging. Cancer Res 78:4660–4660Google Scholar